What Gencovery does

Gencovery is a French life-sciences data infrastructure company founded in 2020 by two PhD-holders from École Centrale de Nantes and École Polytechnique, headquartered in Lyon and operating as GENCOVERY SAS (SIREN 882 921 570). The company develops Constellab™, a sovereign, open-source, modular digital platform serving pharmaceutical, biotech, CRO, CDMO, agronomy and healthcare organisations across the European life-sciences value chain — from fundamental research through clinical development to patient data. Named customers include Bayer (contracted since 2021), Adisseo (since 2022), Institut Imagine (AP-HP), Greencell, Conidia Coniphy, Vibiosphen and TransCure bioServices.

Constellab is architected as a multi-layer system: data connectors, a pipeline engine, an AI/ML layer with native generative-AI agents (integrating Claude, Mistral and OpenAI), sovereign secure storage with full audit trail and lineage, a no-code app builder, and a REST API with Python SDK. It deploys across OVHcloud, Azure, AWS, GCP, Scaleway, Outscale, on-premise or pre-configured Edge hardware, with no cloud lock-in. Application modules include Constellab Care (medical records and patient data), Constellab Digital Twin (bioprocess simulation), Constellab Bioprocess (fermentation monitoring), Constellab Suite (Project, Analytics, Search), and FungiRESIST (fungicide-resistance prediction). The platform is natively aligned with HDS, GDPR, GxP, 21 CFR Part 11, ISO 13485 and ISO 27001.

Gencovery operates a hybrid go-to-market combining freemium product-led growth (Open Access tier), tiered SaaS subscriptions (Starter €390/month, Business €959/month), usage-based Data Lab cloud billing, Edge hardware from €3,000, professional services, and enterprise field sales with dedicated Customer Success. Distribution is amplified by the open-source Constellab Community marketplace, the annual Constellab Connect event, AFSSI Data/AI working group chairmanship (130+ CROs), and the 2026 CROPulse consortium of seven founding partners. In 2026 Gencovery became a Mission-driven company (Entreprise à Mission) and is raising via BSA-AIR convertible notes at a €5M valuation targeting €50M by 2027-2028.

Name

Gencovery

Legal name

GENCOVERY Société par Actions Simplifiée (SAS)

Website

https://gencovery.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Gencovery is a Lyon-based French company developing Constellab, a sovereign, open-source data and AI platform serving pharmaceutical, biotech, CRO, CDMO, agronomy, and healthcare organisations across the European life-sciences value chain.

Ownership category

akta.pro rank

Product category

Life Sciences Data Platform

NAICS

Software Publishers (513210), Computer Systems Design and Related Services (54151)

SIC

Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)

akta.pro primary industry

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

akta.pro secondary industries

Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN), Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Life sciences software
• Bioprocess digital twins
• Sovereign cloud platform
• Lab automation software
• Clinical data management

Headquarters

HQ city

Lyon

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

1. SaaS Platform Subscription: Constellab offers tiered subscription plans (Open Access, Starter, Business, Enterprise) with annual or monthly billing. Plans include workspace configuration, user seats, support levels, and Data Hub Server with dedicated vCPU, RAM, and storage. Enterprise includes white label and custom SLA.
2. Data Lab Infrastructure: Separate compute and storage infrastructure layer with pay-as-you-go cloud pricing. Options include Desktop (free), Cloud (pay per usage), On-premises (contact sales), and Edge devices (from €3,000 excl. tax). Billed independently of subscription cycle.
3. Professional Services: Training, coaching, and dedicated support services offered alongside platform deployment. Evaluation of digital maturity, skill building on tools, AI and compliance. Enterprise customers receive dedicated Customer Success managers and integration support.

Pricing tiers

Go-to-market motion4 records

Distribution channels6 records

Marketing channels7 records

Core offering

Gencovery develops and sells Constellab™, a sovereign, open-source, modular digital platform that consolidates life sciences and health data management across the pharmaceutical value chain. The platform combines data connectors, a pipeline engine, an AI/ML layer, secure storage with audit trail, a no-code app builder, and a REST API with Python SDK, deployable on AWS, Azure, OVHcloud, Scaleway, on-premise or Edge devices. Branded applications built on Constellab (Care, Digital Twin, Bioprocess, Suite, FungiRESIST) deliver use-case-specific solutions for medical records, bioprocess optimization, scientific productivity, and agronomy, complemented by tiered subscriptions and professional services.

Product overview

Gencovery's Constellab™ is a sovereign, open-source, modular platform for life sciences and health data management. It consists of a core platform layer (providing end-to-end lab automation, AI/ML capabilities, multi-cloud and on-premise deployment, a REST API with Python SDK, and data connectors) and a growing ecosystem of branded applications built on top of it. The application portfolio spans Constellab Suite (Project, Analytics, Search), Constellab Care (medical records management), Constellab Digital Twin (bioprocess simulation), Constellab Bioprocess (fermentation monitoring), and FungiRESIST (agronomy), with additional modules in development (Labflow, BioXplorer, 16S rRNA-seq). Infrastructure offerings include sovereign cloud (OVHcloud, Azure, AWS, GCP, Scaleway), on-premise, and Constellab Edge (pre-configured physical device).

Differentiator

Problem solved

Functional benefit

Brands

• Constellab™: The main data and AI platform developed by Gencovery for life sciences organizations, enabling scientific data management, analysis, and sharing in a sovereign, secure and reproducible environment.
• Constellab Care
• Constellab Suite
• Constellab Digital Twin
• FungiRESIST™

Products and services

• Constellab Platform The sovereign, open-source, modular digital platform for life sciences and health data management. Supports multi-cloud and on-premise deployment, end-to-end lab automation (collection, annotation, storage, processing, AI analysis, delivery), and provides the foundation for all Constellab applications. Architecture includes data connectors, pipeline engine, AI/ML layer, secure storage, app builder, and REST API with Python SDK.
• Constellab Care AI-powered medical records management and patient data valorization application built on the Constellab platform. Provides clinical AI agents for natural-language querying of medical records, patient dashboards, HL7/FHIR interoperability, and full audit trail for HDS and GDPR compliance.
• Constellab Digital Twin Bioprocess digital twin application that builds mathematical models calibrated on real fermentation data to simulate, predict and optimise bioprocesses in silico, reducing experimental cycles and maximising yields. Natively integrates with Constellab Bioprocess dashboards and instruments.
• Constellab Bioprocess Fermentation monitoring and analysis application providing real-time dashboards for kinetics, yields and production variances, with multi-format file consolidation (XLS, CSV, TXT) and direct instrument connectivity for bioprocess optimisation.
• Constellab Suite Productivity suite bundling three applications — Constellab Project (project and task management), Constellab Analytics (no-code data visualisation and dashboards), and Constellab Search (semantic search across documents) — in a single sovereign, interoperable workspace.
• Constellab Project Intelligent project management application providing Kanban and Gantt views, task management, client CRM features, and direct connections to scientific data. Centralises projects, tasks and clients in a unified workspace with full traceability.
• Constellab Analytics No-code data analytics application enabling interactive dashboards and data exploration without writing code. Available as part of Constellab Suite and as a standalone Constellab application.
• Constellab Search Semantic search application using conversational AI (RAG) to navigate document bases, publications and scientific results. Available as part of Constellab Suite and as a standalone Constellab application.
• FungiRESIST Fungicide resistance monitoring and prediction digital tool built for Conidia-Coniphy. Predicts and manages fungal resistance using field data, nanopore sequencing and genomics. Anticipates rare variants before they spread and optimises pesticide use.
• Constellab Edge On-premise Edge computing offering providing preconfigured Constellab instances with ready-made business apps delivered as a physical device (Intel Core i7 or AMD Ryzen, configurable RAM 8-64 GB, 512 GB/1 TB disk). Enables full data sovereignty at customer sites with pre-configured Project, Stats, ML and AI apps. One-year warranty included, from €3,000 excl. tax.
• Constellab 16S rRNA-seq 16S rRNA sequence analysis application for exploring microbial diversity of samples. Available on the Constellab Community marketplace.

Quantifiable outcome

• 250h saved per year per practitioner
• +7 more outcomes

Named customers7 records

Segments7 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration32 records

AI capability9 records

Feature8 records

Partnerships

15 partnerships are on record, tiered core and minor.

• Les Ponts de Mariane FoundationcoreStrategic or Co-development Partner · 1 January 2026Mission-driven foundation created by co-founder Djomnagan Adama Ouattara. 3 cents of every euro invested go to building digital bridges for vulnerable populations, primarily in Africa. Enshrined in Gencovery's mission-driven company status.
• CROPulse Consortium PartnerscoreStrategic or Co-development Partner · 1 January 2026CROPulse consortium includes 7 founding partners: ArchParc, Auvergne-Rhône-Alpes, SupBiotech, Medicalps, TransCure bioServices, Mabdesign, XEFI. Collaborative project to structure CRO digitalisation.
• AFSSIcoreStrategic or Co-development Partner · 1 January 2024Gencovery chairs a Data/AI working group with AFSSI (Association Française des Sociétés de Service et d'Innovation in life sciences). 130+ CRO companies in France represented.
• ArchParccoreStrategic or Co-development Partner · 1 January 2024Regional industrial business park hosting companies in health and life sciences. Partnership to support companies in digitization and data valorization. Venue for Constellab Connect 2026.
• Beckman-CoultercoreTechnology or Integration · 1 January 2023Partnership signed to drive lab instruments directly from Constellab. Led to Constellab Edge offering - pre-configured instances with ready-made business apps at customer sites.
• Microsoft AzurecoreTechnology or Integration · 1 January 2023Constellab shipped on Microsoft Azure in 2023, expanding multi-cloud deployment options for customers.
• SupBiotechminorStrategic or Co-development Partner · 1 January 2023Partnership with SupBiotech on AI and bioinformatics training. Educational collaboration supporting talent development.
• Institut Imagine (AP-HP)coreStrategic or Co-development Partner · 1 January 2023Partnership with Institut Imagine (AP-HP) to apply digital twins to metabolic mechanisms of rare genetic diseases. High-profile reference client.
• AdisseocoreStrategic or Co-development Partner · 1 January 2022Constellab deployed on OVHcloud and adopted by Adisseo for animal-nutrition R&D in 2022. Validated platform adoption by industry leader.
• OVHcloudcoreTechnology or Integration · 1 January 2022Constellab launched on OVHcloud in 2022, providing sovereign cloud hosting in France. First major cloud deployment partner for the platform.
• GreencellcoreStrategic or Co-development Partner · 1 January 2022Gencovery-Greencell-BIOASTER partnership for 2nd-generation digital twins to reinforce bioprocesses through AI. Partnership for bioprocess optimization.
• BayercoreStrategic or Co-development Partner · 1 January 2021First contract signed with Bayer in Lyon in 2021. Constellab used in R&D to understand microorganism biology combining AI and digital twins for crop-protection products.
• BIOASTER Technological Research InstitutecoreStrategic or Co-development Partner · 1 January 2020Gencovery was founded with support from BIOASTER Technological Research Institute. This partnership provided technological research institute backing during founding in 2020.
• SATT PULSALYScoreStrategic or Co-development Partner · 1 January 2020Gencovery was incubated by SATT PULSALYS (Société d'Accélération du Transfert de Technologies). This technology transfer accelerator supported the company's early development.
• LifeHub Lyon (Bayer)coreStrategic or Co-development Partner · 1 January 2020Gencovery was incubated by LifeHub Lyon, part of Bayer. This provided early access to pharmaceutical industry expertise and networks.

Scale indicators10 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• BIOVIA (Dassault Systèmes): Dassault Systèmes' scientific brand covering ELN, LIMS, molecular modelling and biologics design across enterprise life sciences. Named by Gencovery as a competitor; significantly larger incumbent with broader portfolio.
• Veeva Systems: Cloud software provider for life sciences across R&D, regulatory, quality and commercial. Overlaps with Constellab in regulated life-sciences data management but is a much larger, publicly traded incumbent serving global pharma.
• ArisGlobal: Life-sciences R&D platform covering safety, regulatory, clinical and medical affairs. Comparable in regulated life-sciences software, especially around GxP compliance and submission workflows that Constellab addresses.

Emerging players

• Owkin: AI-for-life-sciences platform combining federated learning, multi-omics and clinical data with a focus on European, sovereign AI infrastructure. Comparable to Constellab's positioning around sovereign AI for pharma and health.
• SciBite (Elsevier): Scientific data and literature intelligence platform using semantic AI to structure biomedical text. Comparable to Constellab Search and the platform's literature intelligence/Knowledge Management layer.

Direct peers

• Benchling: Cloud-based R&D platform for life sciences covering ELN, LIMS, registry, inventory and workflow automation. Gencovery explicitly names Benchling as a primary competitor and positions Constellab as the sovereign, open-source, mid-market-accessible alternative.
• LabVantage Solutions: Enterprise LIMS vendor serving pharma, biotech, food and diagnostics. Gencovery explicitly lists LabVantage as a competitor for lab data management and GxP-ready workflows.
• Dotmatics: Scientific informatics platform (LIMS, ELN, data analysis) used across pharma and biotech R&D. Named by Gencovery as a competitor; comparable in offering breadth but differs on data sovereignty, openness and European hosting posture.
• DNAnexus: Cloud genomics and multi-omics data platform serving pharma, clinical and research customers. Gencovery names DNAnexus as a competitor; both target life-sciences data management and bioinformatics pipelines at scale.
• TetraScience: Scientific data cloud and R&D Data Lakehouse for life sciences, federating instrument and lab data into a unified platform. Closely comparable to Constellab's 'Scientific Data Management & Data Platforms' positioning and FAIR-compliant data fabric approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/gencovery
• Xx.com/Gencovery

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gencovery